Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind Placebo-controlled Phase I Study to Assess Safety, Tolerance and Pharmacokinetics of a Single Intravenous Injection Kukoamine B Mesilate in Healthy Volunteers

NCT02219971 is registered in ClinicalTrials.gov with Tianjin Chasesun Pharmaceutical Co., LTD as lead sponsor.

NCT NCT02219971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02219971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind Placebo-controlled Phase I Study to Assess Safety, Tolerance and Pharmacokinetics of a Single Intravenous Injection Kukoamine B Mesilate in Healthy Volunteers
Lead sponsor
Tianjin Chasesun Pharmaceutical Co., LTD
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2014
Completion date
May 6, 2015
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy